UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063310
Receipt number R000072402
Scientific Title Constipation Management Insights and Trend
Date of disclosure of the study information 2026/10/16
Last modified on 2026/10/16 12:30:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Constipation Management Insights and Trend

Acronym

COMMIT study

Scientific Title

Constipation Management Insights and Trend

Scientific Title:Acronym

COMMIT study

Region

Japan


Condition

Condition

chronic constipation

Classification by specialty

Medicine in general Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to evaluate temporal changes in the use of medications for constipation treatment in Japan and to investigate whether outcomes of constipation management, including the proportion of stimulant laxative use, enema utilization rates, and manual disimpaction rates, have changed over time.

Basic objectives2

Others

Basic objectives -Others

To evaluate temporal trends in constipation medication use and changes in outcomes, including enema administration and manual disimpaction, using a large-scale claims database.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Annual utilization rates of constipation medications

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with a diagnosis of constipation recorded in the JMDC (Japan Medical Data Center) health insurance claims database between 2005 and 2025.

Key exclusion criteria

None

Target sample size

800000


Research contact person

Name of lead principal investigator

1st name Toshiki
Middle name
Last name Takatsuki

Organization

EA Pharma Co.,Ltd.

Division name

Medical Science Group, Medical Dept.

Zip code

104-0042

Address

2-1-1, Irifune, Chuo-ku, Tokyo Japan

TEL

08043536796

Email

toshiki_takatsuki@eapharma.co.jp


Public contact

Name of contact person

1st name Toshiki
Middle name
Last name Takatsuki

Organization

EA Pharma Co.,Ltd.

Division name

Medical Science Group, Medical Dept.

Zip code

1040042

Address

2-1-1, Irifune, Chuo-ku, Tokyo Japan

TEL

08043536796

Homepage URL


Email

toshiki_takatsuki@eapharma.co.jp


Sponsor or person

Institute

EA Pharma Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

EA Pharma Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamauchi Clinic Research Ethics Committee

Address

1-15-9 Jiyugaoka, Meguro-ku, Tokyo, Jaoan

Tel

03-6777-1490

Email

c-irb_ug@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 30 Day

Date of IRB

2026 Year 10 Month 15 Day

Anticipated trial start date

2026 Year 10 Month 16 Day

Last follow-up date

2026 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational study


Management information

Registered date

2026 Year 10 Month 16 Day

Last modified on

2026 Year 10 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072402